Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease

INTRODUCTION: Cerebrospinal fluid α-synuclein level is increased in sporadic Creutzfeldt-Jakob disease cases. However, the clinical value of this biomarker remains to be established. In this study, we have addressed the clinical validation parameters and the interlaboratory reproducibility by using...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Alzheimers Dement (Amst)
Autori principali: Kruse, Niels, Heslegrave, Amanda, Gupta, Vandana, Foiani, Martha, Villar-Piqué, Anna, Schmitz, Matthias, Lehmann, Sylvain, Teunissen, Charlotte, Blennow, Kaj, Zetterberg, Henrik, Mollenhauer, Brit, Zerr, Inga, Llorens, Franc
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2018
Soggetti:
CSF Biomarkers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6171371/
https://ncbi.nlm.nih.gov/pubmed/30294658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2018.06.005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi